Clinical Trial Update: Open Label Arimidex in Gynecomastia [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial evaluating Arimidex (anastrozole) for gynecomastia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecomastia

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Gynecomastia | Phase 2 | Status: COMPLETED